Stepping Forward to the Next Level: Totality of Evidence for the First High-Concentration Adalimumab Biosimilar, CT-P17 Ombretta ViapianaSoohyun LeeBruno Fautrel Leading Article 13 January 2022 Pages: 103 - 112
Informing and Empowering Patients and Clinicians to Make Evidence-Supported Outcome-Based Decisions in Relation to SGLT2 Inhibitor Therapies: The Use of the Novel Years of Drug administration (YoDa) Concept Lakshminarayanan VaradhanPonnusamy SaravananVinod Patel Practical Application 02 February 2022 Pages: 113 - 125
Opicapone for the Treatment of Parkinson’s Disease "Off" Episodes: Pharmacology and Clinical Considerations Amnon A. BergerChristopher RobinsonIvan Urits Review Article 21 December 2021 Pages: 127 - 135
Safety, Pharmacokinetics and Pharmacodynamics of DS-1040, in Combination with Thrombectomy, in Japanese Patients with Acute Ischemic Stroke Nobuyuki SakaiMasataka TakeuchiShigeru Fujimoto Original Research Article Open access 21 January 2022 Pages: 137 - 149
Comparative Bioavailability Study of a New Vitamin D3 Orodispersible Film Versus a Marketed Oral Solution in Healthy Volunteers Milko RadicioniCarol CaverzasioGiuseppe Mautone Original Research Article Open access 16 January 2022 Pages: 151 - 161
Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial C. Louwrens BraalAnne KleijburgCarin A. Uyl-de Groot Original Research Article Open access 12 January 2022 Pages: 163 - 175
Adverse Events with d-penicillamine Therapy in Hepatic Wilson’s Disease: A Single-Center Retrospective Audit Sanjay KumarBiswa Ranjan PatraAkash Shukla Short Communication 31 January 2022 Pages: 177 - 184
Next-Generation Sequencing Liquid Biopsy-Guided Osimertinib Rechallenge in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients Vered FuchsWaleed KianLaila C. Roisman Short Communication 19 January 2022 Pages: 185 - 192
